Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both

Por Ghushchyan, Vahram, Nair, Kavita V, Page, Robert L
Publicado no Vasc Health Risk Manag (2014)

Impact of Prescription Benefit Coverage Limits on Sevelamer Hydrochloride Adherence for Patients with ESRD

Por Bhardwaja, Bharati, Carroll, Nikki, Korner, Eli, Nair, Kavita V.
Publicado em 2009

Patient-reported outcomes in multiple sclerosis: Validation of the Quality of Life in Neurological Disorders (Neuro-QoL™) short forms

Por Medina, Luis D, Torres, Stephanie, Alvarez, Enrique, Valdez, Brooke, Nair, Kavita V
Publicado no Mult Scler J Exp Transl Clin (2019)

Impact of Treatment by NCQA-Certified Physicians on Diabetes-Related Outcomes

Por Pinsky, Brett, Harnett, James, Paulose-Ram, Ryne, Mardekian, Jack, Samant, Navendu, Nair, Kavita V.
Publicado em 2011

Prescription Copay Reduction Program for Diabetic Employees: Impact on Medication Compliance and Healthcare Costs and Utilization

Por Nair, Kavita V., Miller, Kerri, Saseen, Joseph, Wolfe, Pamela, Allen, Richard Read, Park, Jinhee
Publicado em 2009

Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience

Por Vollmer, Brandi, Nair, Kavita V, Sillau, Stefan H, Corboy, John, Vollmer, Timothy, Alvarez, Enrique
Publicado no Mult Scler J Exp Transl Clin (2017)

Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis

Por Trinkley, Katy E., Anderson, Heather D., Nair, Kavita V., Malone, Daniel C., Saseen, Joseph J.
Publicado no Ther Adv Chronic Dis (2018)

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment

Por Vollmer, Brandi L., Nair, Kavita V., Sillau, Stefan, Corboy, John R., Vollmer, Timothy, Alvarez, Enrique
Publicado no Ann Clin Transl Neurol (2018)

Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes

Por McQueen, R Brett, Ellis, Samuel L, Campbell, Jonathan D, Nair, Kavita V, Sullivan, Patrick W
Publicado em 2011

Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)

Por Carlson, Kevin V., Rovner, Eric S., Nair, Kavita V., Deal, Anna S., Kristy, Rita M., Schermer, Carol R.
Publicado no Adv Ther (2019)

Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era

Por Nicholas, Jacqueline A., Shin, Robert K, Alvarez, Enrique, Hendin, Barry, Nair, Kavita V., Lublin, Fred D.
Publicado no Mult Scler Relat Disord (2021)

Multiple sclerosis prevalence in the United States commercially insured population

Por Dilokthornsakul, Piyameth, Valuck, Robert J., Nair, Kavita V., Corboy, John R., Allen, Richard R., Campbell, Jonathan D.
Publicado no Neurology (2016)

Incremental increases in economic burden parallels cardiometabolic risk factors in the US

Por McQueen, R Brett, Ghushchyan, Vahram, Olufade, Temitope, Sheehan, John J, Nair, Kavita V, Saseen, Joseph J
Publicado no Diabetes Metab Syndr Obes (2016)

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

Por Foley, John F, Nair, Kavita V, Vollmer, Timothy, Stephenson, Judith J, Niecko, Timothy, Agarwal, Sonalee S, Watson, Crystal
Publicado no Patient Prefer Adherence (2017)

The cost of inpatient death associated with acute coronary syndrome

Por Page, Robert L, Ghushchyan, Vahram, Van Den Bos, Jill, Gray, Travis J, Hoetzer, Greta L, Bhandary, Durgesh, Nair, Kavita V
Publicado no Vasc Health Risk Manag (2016)

An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures

Por Pesa, Jacqueline A, Van Den Bos, Jill, Gray, Travis, Hartsig, Colleen, McQueen, Robert Brett, Saseen, Joseph J, Nair, Kavita V
Publicado em 2012

Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis

Por Honce, Justin M., Nair, Kavita V., Sillau, Stefan, Valdez, Brooke, Miravalle, Augusto, Alvarez, Enrique, Schreiner, Teri, Corboy, John R., Vollmer, Timothy L.
Publicado no Neurology (2019)

Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate

Por Honce, Justin M., Nair, Kavita V., Hoyt, Brian D., Seale, Rebecca A., Sillau, Stefan, Engebretson, Eric, Schurr, Brittany, Corboy, John R., Vollmer, Timothy L., Alvarez, Enrique
Publicado no Front Neurol (2020)

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap

Por Page, Robert Lee, Ghushchyan, Vahram, Allen, Richard R, Roper, Lisa, Beck, Don, Jonathan, Bamrom H, Frech-Tamas, Feride, Chan, Wing, McQueen, R Brett, Nair, Kavita V
Publicado em 2012

Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey

Por Nair, Kavita V, Belletti, Daniel A, Doyle, Joseph J, Allen, Richard R, McQueen, Robert B, Saseen, Joseph J, Vande Griend, Joseph, Patel, Jay V, McQueen, Angela, Jan, Saira
Publicado em 2011